Stock HRTX HERON THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Heron Therapeutics, Inc.

Equities

HRTX

US4277461020

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
2.45 USD -3.92% Intraday chart for Heron Therapeutics, Inc. -7.20% +44.12%
04-23 Capital One Starts Heron Therapeutics With Overweight Rating, $6 Price Target MT
03-21 Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024 CI

Evolution of the average Target Price on Heron Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

5cdf0d9c9f8cd9f0fc4568952.OM03pWsuJCzgkyPbC4BAGklycisSa_a6eN4gaeVsYjM.aoxWxC1kUkGypEaQQNhzaSYBARxUKbPXAPMZD78vOmRQgVbmX2R8W6TiVA~41f150a5625c57549c88d1a553fbcd37

Analyst Recommendations on Heron Therapeutics, Inc.

Capital One Starts Heron Therapeutics With Overweight Rating, $6 Price Target MT
Needham Adjusts Price Target on Heron Therapeutics to $5 From $4, Keeps Buy Rating MT
Needham Trims Price Target on Heron Therapeutics to $4 From $5, Keeps Buy Rating MT
Needham Adjusts Price Target on Heron Therapeutics to $5 From $6, Maintains Buy Rating MT
Needham Adjusts Heron Therapeutics' Price Target to $6 From $7, Keeps Buy Rating MT
Needham Adjusts Price Target on Heron Therapeutics to $6 From $7, Maintains Buy Rating MT
Evercore ISI Adjusts Price Target on Heron Therapeutics to $10 From $15, Maintains Outperform Rating MT
Needham Adjusts Price Target on Heron Therapeutics to $7 From $8, Keeps Buy Rating MT
Needham Trims Price Target on Heron Therapeutics to $8 From $10, Maintains Buy Rating MT
Cantor Fitzgerald Adjusts Price Target for Heron Therapeutics to $12 From $20, Maintains Overweight Rating MT
Needham Adjusts Heron Therapeutics' Price Target to $14 from $16, Keeps Buy Rating MT
Cowen & Co Adjusts Heron Therapeutics Price Target to $13 From $31, Maintains Outperform Rating MT
Needham & Co Adjusts Heron Therapeutics Price Target to $16 From $24, Maintains Buy Rating MT
HERON THERAPEUTICS : Stifel Adjusts Heron Therapeutics' Price Target to $25 from $20, Keeps Buy Rating MT
HERON THERAPEUTICS : SVB Leerink Adjusts Heron Therapeutics' Price Target to $24 From $21, Keeps at Outperform MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.45 USD
Average target price
6.75 USD
Spread / Average Target
+175.51%
High Price Target
9 USD
Spread / Highest target
+267.35%
Low Price Target
5 USD
Spread / Lowest Target
+104.08%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Heron Therapeutics, Inc.

Capital One Securities
Needham & Co.
Evercore ISI
Cantor Fitzgerald
Cowen

Ratings for Heron Therapeutics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. HRTX Stock
  4. Consensus Heron Therapeutics, Inc.